Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    March 2017
  1. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed     Text format    


  2. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed     Text format    


  3. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed     Text format    


    February 2017
  4. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed     Text format    


  5. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed     Text format    


    January 2017
  6. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


    November 2016
  7. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed     Text format    


  8. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed     Text format    


  9. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed     Text format    


  10. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed     Text format    


  11. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed     Text format    


    October 2016
  12. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed     Text format    


  13. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Text format     Abstract available


  14. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed     Text format    


  15. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Text format     Abstract available


  16. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Text format     Abstract available


    July 2016
  17. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed     Text format    


  18. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  19. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  20. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


  21. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  22. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    PubMed     Text format     Abstract available


  23. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available


    June 2016
  24. DONALD PR, Van Toorn R
    Use of corticosteroids in tuberculous meningitis.
    Lancet. 2016;387:2585-7.
    PubMed     Text format    


  25. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
    Lancet. 2016;387:2486-7.
    PubMed     Text format    


    March 2016
  26. LEVIN M, Kaforou M
    Predicting active tuberculosis progression by RNA analysis.
    Lancet. 2016 Mar 23. pii: S0140-6736(16)00165.
    PubMed     Text format    


  27. ZAK DE, Penn-Nicholson A, Scriba TJ, Thompson E, et al
    A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
    Lancet. 2016 Mar 23. pii: S0140-6736(15)01316.
    PubMed     Text format     Abstract available


  28. HOSSEINIPOUR MC, Bisson GP, Miyahara S, Sun X, et al
    Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Lancet. 2016;387:1198-209.
    PubMed     Text format     Abstract available


  29. MOHAPATRA PR
    Tuberculosis control.
    Lancet. 2016;387:1160.
    PubMed     Text format    


  30. KRANZER K, Khan P, Godfrey-Fausset P, Ayles H, et al
    Tuberculosis control.
    Lancet. 2016;387:1159-60.
    PubMed     Text format    


  31. BLACK A, Mwansa-Kambafwile J
    Tuberculosis control.
    Lancet. 2016;387:1159.
    PubMed     Text format    


  32. DEL GRANADO M, Lopez R, Victoria J, Volz A, et al
    Tuberculosis control.
    Lancet. 2016;387:1158.
    PubMed     Text format    


  33. FUJIWARA PI, Dlodlo RA
    Tuberculosis control.
    Lancet. 2016;387:1158-9.
    PubMed     Text format    


  34. GODFREY C, Andersen J, Mngqibisa R, Scott LE, et al
    Tuberculosis control.
    Lancet. 2016;387:1157-8.
    PubMed     Text format    


  35. DAS P
    Soumya Swaminathan: re-energising tuberculosis research in India.
    Lancet. 2016;387:1153.
    PubMed     Text format    


  36. GHANASHYAM B
    Changing the game for multidrug-resistant tuberculosis.
    Lancet. 2016;387:1149-50.
    PubMed     Text format    


  37. GODFREY-FAUSSETT P, Ayles H
    Why are people living with HIV still dying of tuberculosis?
    Lancet. 2016;387:1141-3.
    PubMed     Text format    



  38. Unite to end tuberculosis.
    Lancet. 2016;387:1134.
    PubMed     Text format    


  39. KERKHOFF AD, Lawn SD
    A breakthrough urine-based diagnostic test for HIV-associated tuberculosis.
    Lancet. 2016 Mar 9. pii: S0140-6736(16)00146.
    PubMed     Text format    


  40. PETER JG, Zijenah LS, Chanda D, Clowes P, et al
    Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Lancet. 2016 Mar 9. pii: S0140-6736(15)01092.
    PubMed     Text format     Abstract available


    February 2016
  41. DHEDA K
    Tuberculosis and Poncet's disease: the many faces of an old enemy.
    Lancet. 2016;387:618.
    PubMed     Text format    


  42. ARORA S, Prakash TV, Carey RA, Hansdak SG, et al
    Poncet's disease: unusual presentation of a common disease.
    Lancet. 2016;387:617-8.
    PubMed     Text format    


    January 2016
  43. USHER AD
    Global Fund plays hard ball on corruption.
    Lancet. 2016;387:213-4.
    PubMed     Text format    


    December 2015
  44. RITZ N, Brinkmann F, Garcia BS, Tebruegge M, et al
    Tuberculosis in young refugees.
    Lancet. 2015;386:2475-6.
    PubMed     Text format    


  45. BURKI T
    Ethiopia could be a model country for tuberculosis control.
    Lancet. 2015;386:2241-2.
    PubMed     Text format    


    October 2015
  46. FURIN J, Akugizibwe P, Ditiu L, Gray G, et al
    No one with HIV should die from tuberculosis.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00319.
    PubMed     Text format    


  47. WATTS G
    Salmaan Keshavjee: tackling tuberculosis (without rocket science).
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00466.
    PubMed     Text format    


  48. KESHAVJEE S, Dowdy D, Swaminathan S
    Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00320.
    PubMed     Text format    


  49. RANGAKA MX, Cavalcante SC, Marais BJ, Thim S, et al
    Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00323.
    PubMed     Text format     Abstract available


  50. ORTBLAD KF, Salomon JA, Barnighausen T, Atun R, et al
    Stopping tuberculosis: a biosocial model for sustainable development.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00324.
    PubMed     Text format     Abstract available


  51. DAS P, Horton R
    Tuberculosis-getting to zero.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00401.
    PubMed     Text format    


  52. THERON G, Jenkins HE, Cobelens F, Abubakar I, et al
    Data for action: collection and use of local data to end tuberculosis.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00321.
    PubMed     Text format     Abstract available


  53. YUEN CM, Amanullah F, Dharmadhikari A, Nardell EA, et al
    Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00322.
    PubMed     Text format     Abstract available


    September 2015
  54. DHEDA K, Barry CE 3rd, Maartens G
    Tuberculosis.
    Lancet. 2015 Sep 11. pii: S0140-6736(15)00151.
    PubMed     Text format     Abstract available


  55. SHARMA DC
    Budget cuts threaten AIDS and tuberculosis control in India.
    Lancet. 2015;386:942.
    PubMed     Text format    


    May 2015
  56. MINGOTE LR, Namutamba D, Seaworth B, Lee C, et al
    Informed use of bedaquiline for tuberculosis--Authors' reply.
    Lancet. 2015;385:1725.
    PubMed     Text format    


  57. LESSEM EM, Bernardo J, Reed C, Wegener DH, et al
    Informed use of bedaquiline for tuberculosis.
    Lancet. 2015;385:1724.
    PubMed     Text format    


  58. FURIN J
    Informed use of bedaquiline for tuberculosis.
    Lancet. 2015;385:1724-5.
    PubMed     Text format    


  59. SOTGIU G, Migliori GB
    New effective antituberculosis regimens.
    Lancet. 2015;385:1703-4.
    PubMed     Text format    


  60. UPLEKAR M, Weil D, Lonnroth K, Jaramillo E, et al
    WHO's new end TB strategy.
    Lancet. 2015;385:1799-801.
    PubMed     Text format    


    April 2015
  61. JIA Z, Ruan Y, Lu Z
    HIV incidence and mortality in China.
    Lancet. 2015;385:1510.
    PubMed     Text format    


    March 2015
  62. SUPERVIE V, Archibald CP, Costagliola D, Delpech V, et al
    GBD 2013 and HIV incidence in high income countries.
    Lancet. 2015;385:1177.
    PubMed     Text format    


  63. DAWSON R, Diacon AH, Everitt D, van Niekerk C, et al
    Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant
    Lancet. 2015 Mar 17. pii: S0140-6736(14)62002.
    PubMed     Text format     Abstract available


    February 2015
  64. HILL PC, Whalen CC
    Prevalence of tuberculosis in China.
    Lancet. 2015;385:773.
    PubMed     Text format    


    January 2015
  65. GOLECHHA M
    Can India be tuberculosis-free by 2050?
    Lancet. 2015;385:328-9.
    PubMed     Text format    


  66. KOSER CU, Javid B, Liddell K, Ellington MJ, et al
    Drug-resistance mechanisms and tuberculosis drugs.
    Lancet. 2015;385:305-7.
    PubMed     Text format    


  67. ABUBAKAR I, Thomas HL, Morgan M, Anderson S, et al
    A collaborative strategy to tackle tuberculosis in England.
    Lancet. 2015 Jan 16. pii: S0140-6736(14)61638.
    PubMed     Text format    


    December 2014
  68. TEBRUEGGE M, Bogyi M, Soriano-Arandes A, Kampmann B, et al
    Shortage of purified protein derivative for tuberculosis testing.
    Lancet. 2014;384:2026.
    PubMed     Text format    


    November 2014
  69. KHAN MS, Coker RJ
    Tuberculosis control: hard questions - Authors' reply.
    Lancet. 2014;384:1744-5.
    PubMed     Text format    


  70. WEYER K, Falzon D, Wares F, Jaramillo E, et al
    Tuberculosis control: hard questions.
    Lancet. 2014;384:1744.
    PubMed     Text format    


  71. SHANKS GD
    How World War 1 changed global attitudes to war and infectious diseases.
    Lancet. 2014;384:1699-707.
    PubMed     Text format     Abstract available


    October 2014
  72. ACOSTA CD, Kaluski DN, Dara M
    Conflict and drug-resistant tuberculosis in Ukraine.
    Lancet. 2014;384:1500-1.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: